BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38786176)

  • 21. Whole Genome Sequencing of Extended-Spectrum- and AmpC- β-Lactamase-Positive Enterobacterales Isolated From Spinach Production in Gauteng Province, South Africa.
    Richter L; du Plessis EM; Duvenage S; Allam M; Ismail A; Korsten L
    Front Microbiol; 2021; 12():734649. PubMed ID: 34659162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Modifying Empirical Antibiotic Therapy Based on Intestinal Colonization Status on Clinical Outcomes of Febrile Neutropenic Patients.
    Alrstom A; Alsuliman T; Daher N; Abouharb R
    Infect Chemother; 2021 Mar; 53(1):63-74. PubMed ID: 33538132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Retrospective Analysis of Risk Factors and Patient Outcomes of Bloodstream Infection with Extended-Spectrum β-Lactamase-Producing
    Xiao Y; Hang Y; Chen Y; Fang X; Cao X; Hu X; Luo H; Zhu H; Zhu W; Zhong Q; Hu L
    Infect Drug Resist; 2020; 13():4289-4296. PubMed ID: 33262623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spreading of extended-spectrum β-lactamase-producing Escherichia coli ST131 and Klebsiella pneumoniae ST11 in patients with pneumonia: a molecular epidemiological study.
    Liu J; Du SX; Zhang JN; Liu SH; Zhou YY; Wang XR
    Chin Med J (Engl); 2019 Aug; 132(16):1894-1902. PubMed ID: 31408445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing
    Liang T; Xu C; Cheng Q; Tang Y; Zeng H; Li X
    Microb Drug Resist; 2021 Jun; 27(6):800-808. PubMed ID: 33232654
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical and Molecular Findings of Infections Caused by Extended-Spectrum β-Lactamase-Producing
    Szymankiewicz M; Stefaniuk E; Baraniak A; Nowikiewicz T
    Microb Drug Resist; 2021 Nov; 27(11):1470-1481. PubMed ID: 34264754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
    Satlin MJ; Chen L; Douglass C; Hovan M; Davidson E; Soave R; La Spina M; Gomez-Arteaga A; van Besien K; Mayer S; Phillips A; Hsu JM; Malherbe R; Small CB; Jenkins SG; Westblade LF; Kreiswirth BN; Walsh TJ
    Clin Infect Dis; 2021 Oct; 73(7):1257-1265. PubMed ID: 33956965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z; Zhu D; Zhang Y; Wang F
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections.
    Xiao T; Wu Z; Shi Q; Zhang X; Zhou Y; Yu X; Xiao Y
    J Glob Antimicrob Resist; 2019 Jun; 17():147-156. PubMed ID: 30634054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for colonization with multiple species of extended-spectrum beta-lactamase producing Enterobacterales: a case-case-control study.
    Vock I; Aguilar-Bultet L; Egli A; Tamma PD; Tschudin-Sutter S
    Antimicrob Resist Infect Control; 2021 Oct; 10(1):153. PubMed ID: 34689820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology and pathogenomics of extended-spectrum beta-lactamase producing-
    Gelalcha BD; Mohammed RI; Gelgie AE; Kerro Dego O
    Front Microbiol; 2023; 14():1283165. PubMed ID: 38029210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for Extended-Spectrum-β-Lactamase-Producing
    Baek YJ; Kim YA; Kim D; Shin JH; Uh Y; Shin KS; Shin JH; Jeong SH; Lee GW; Lee EJ; Kim DS; Park YS
    Ann Lab Med; 2021 Sep; 41(5):455-462. PubMed ID: 33824233
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Stewart AG; Cottrell K; Henderson A; Vemuri K; Bauer MJ; Paterson DL; Harris PNA
    Microbiol Spectr; 2021 Sep; 9(1):e0022621. PubMed ID: 34232101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole Genome Sequencing of Extended Spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae Isolated from Hospitalized Patients in KwaZulu-Natal, South Africa.
    Founou RC; Founou LL; Allam M; Ismail A; Essack SY
    Sci Rep; 2019 Apr; 9(1):6266. PubMed ID: 31000772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug-Resistant and Extended-Spectrum β-Lactamase (ESBL) - Producing
    Zemtsa RJ; Noubom M; Founou LL; Dimani BD; Koudoum PL; Mbossi AD; Kouanfack C; Founou RC
    Pathogens; 2022 Apr; 11(5):. PubMed ID: 35631025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and molecular characterization of fecal carriage of third-generation cephalosporin-resistant Enterobacterales among elderly residents in Japan.
    Nakai M; Oka K; Watanabe G; Kamei K; Tsukada N; Mori R; Nagaya M; Ukai Y; Morioka H; Tetsuka N; Iguchi M; Yagi T
    J Infect Chemother; 2022 Apr; 28(4):569-575. PubMed ID: 35039227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for and mortality of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections.
    Superti SV; Augusti G; Zavascki AP
    Rev Inst Med Trop Sao Paulo; 2009; 51(4):211-6. PubMed ID: 19739001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018.
    Kohler P; Wolfensberger A; Stampf S; Brönnimann A; Boggian K; van Delden C; Favre M; Hirzel C; Khanna N; Kuster SP; Manuel O; Neofytos D; Ragozzino S; Schreiber PW; Walti L; Mueller NJ;
    Antimicrob Resist Infect Control; 2021 Mar; 10(1):50. PubMed ID: 33678189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole Genome Sequencing of Extended-Spectrum Beta-Lactamase-Producing
    Mairi A; Meyer S; Tilloy V; Barraud O; Touati A
    Microb Drug Resist; 2022 Aug; 28(8):867-876. PubMed ID: 35759367
    [No Abstract]   [Full Text] [Related]  

  • 40. The fecal carriage rate of extended-spectrum β-lactamase-producing or carbapenem-resistant
    Kawata S; Morimoto S; Kosai K; Kawamoto Y; Nakashima Y; Morinaga Y; Yanagihara K; Yoshida LM; Moriuchi H
    Front Cell Infect Microbiol; 2023; 13():1168451. PubMed ID: 37389210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.